The first widespread deployment of RSV preventive measures in winter 2024-25, including maternal vaccines and monoclonal antibody treatments, has led to a significant decrease in infant hospitalizations. Rates have dropped by up to 71% in newborns under two months compared to pre-pandemic levels.
CDC: RSV Vaccines Cut Infant Hospitalizations by Up to 71%